IDEX CORP DE
For the period ended Mar 31, 2025. Filed May 1, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 1, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities | ||
| Net income | $95.4 | $121.3 |
| Adjustments to reconcile net income to net cash flows provided by operating activities: | ||
| Depreciation | 18.4 | 16.2 |
| Amortization of intangible assets | 31.5 | 24.6 |
| Share-based compensation expense | 13.6 | 12.5 |
| Deferred income taxes | 0.9 | 0.2 |
| Changes in (net of the effect from acquisitions/divestitures and foreign currency translation): | ||
| Receivables – net | (12.3) | (12.2) |
| Inventories – net | (34.9) | (9.5) |
| Other current assets | (7.0) | (10.9) |
| Trade accounts payable | 9.6 | 8.9 |
| Deferred revenue | 8.8 | 6.8 |
| Accrued expenses | (17.9) | (1.5) |
| Other – net | (0.4) | 0.2 |
| Net cash flows provided by operating activities | 105.7 | 156.6 |
| Cash flows from investing activities | ||
| Capital expenditures | (14.3) | (20.0) |
| Acquisition of business, net of cash acquired | 4.2 | — |
| Other – net | 0.1 | — |
| Net cash flows used in investing activities | (10.0) | (20.0) |
| Cash flows from financing activities | ||
| Payments under revolving credit facilities | (30.2) | — |
| Cash dividends paid to shareholders | (52.4) | (48.5) |
| (Payments) proceeds from share issuances, net of shares withheld for taxes | (0.5) | 7.7 |
| Repurchases of common stock | (50.0) | — |
| Other – net | (0.2) | (0.2) |
| Net cash flows used in financing activities | (133.3) | (41.0) |
| Effect of exchange rate changes on cash and cash equivalents | 10.9 | (13.6) |
| Net (decrease) increase in cash and cash equivalents and restricted cash | (26.7) | 82.0 |
| Cash and cash equivalents and restricted cash at beginning of year(1) | 638.9 | 534.3 |
| Cash and cash equivalents and restricted cash at end of period(1) | $612.2 | $616.3 |
| Supplemental cash flow information | ||
| Cash paid for: | ||
| Interest | $15.6 | $2.4 |
| Income taxes – net | 19.8 | 18.4 |
(1)Includes $18.1 million of restricted cash at March 31, 2025 and December 31, 2024. At March 31, 2025, $16.5 million of the restricted cash has been included in Other current assets and $1.6 million has been included in Other noncurrent assets in the Condensed Consolidated Balance Sheets. At December 31, 2024, $18.1 million was included in Other current assets in the Condensed Consolidated Balance Sheets. There wasno restricted cash as of March 31, 2024 or December 31, 2023.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.